PRO-DEX, INC. Current Liabilities
PRO-DEX, INC. (PDEX) had Current Liabilities of $12.98 million as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-09-03
- 2026-06-30: Liabilities, Current $12.98M.
- 2026-03-31: Liabilities, Current $14.64M.
- 2025-12-31: Liabilities, Current $12.20M.
- 2025-09-30: Liabilities, Current $13.60M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $12.98M 10-K · filed 2026-09-03 | |
| 2026-03-31 | $14.64M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $12.20M 10-Q · filed 2026-01-29 | |
| 2025-09-30 | $13.60M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $14.63M 10-K · filed 2026-09-03 | |
| 2025-03-31 | $18.32M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $17.14M 10-Q · filed 2025-01-30 | |
| 2024-09-30 | $11.29M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $12.89M 10-K · filed 2025-09-04 | |
| 2024-03-31 | $10.42M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $9.99M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $8.28M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $9.68M 10-K · filed 2024-09-05 | |
| 2023-03-31 | $10.14M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $11.66M 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $11.67M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $11.35M 10-K · filed 2023-10-13 | |
| 2022-03-31 | $7.72M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $5.97M 10-Q · filed 2022-02-03 | |
| 2021-09-30 | $6.21M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $6.27M 10-K · filed 2022-09-08 | $5.87M 10-K · filed 2021-09-09 |
| 2021-03-31 | $6.48M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $4.93M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $4.45M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $5.23M 10-K · filed 2021-09-09 | |
| 2020-03-31 | $4.44M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.95M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $3.55M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.27M 10-K · filed 2020-09-10 | |
| 2019-03-31 | $3.75M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.67M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $2.90M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.42M 10-K · filed 2019-09-12 | $2.54M 10-K · filed 2018-09-13 |
| 2018-03-31 | $1.96M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.97M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $1.79M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.58M 10-K · filed 2018-09-13 | |
| 2017-03-31 | $2.35M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $2.72M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $2.65M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $2.16M 10-K · filed 2017-09-14 | $2.08M 10-K · filed 2016-09-15 |
| 2016-03-31 | $2.17M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $3.13M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $3.61M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $3.69M 10-K · filed 2016-09-15 | |
| 2015-03-31 | $3.78M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $2.69M 10-Q · filed 2015-02-10 | |
| 2014-09-30 | $2.13M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $2.13M 10-K · filed 2015-09-17 | |
| 2014-03-31 | $2.21M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $2.02M 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $1.89M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $2.31M 10-K · filed 2014-09-18 | |
| 2013-03-31 | $2.25M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $1.63M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $2.62M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $2.88M 10-K · filed 2013-09-27 | |
| 2012-03-31 | $3.38M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $3.75M 10-Q · filed 2012-02-07 | |
| 2011-09-30 | $3.40M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $4.02M 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |